CommunityOne Bancorp (COB1)

Sector:
FINANCE
Industry:
FINANCE
SIC:
NATIONAL COMMERCIAL BANKS
CEO:
Alicia Secor
Employees:
139
33 ARCH STREET, SUITE 3110, BOSTON, MA 02110
617-639-1500

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Juniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., is a pharmaceutical company that engages in the development of therapeutics that addresses unmet medical needs in women's health. Its pipeline development is funded by cash flows from its CRINONE franchise and services business. It is currently developing COL-1077, a 10% lidocaine bioadhesive gel intended as an acute use anesthetic for minimally invasive gynecological procedures. The company was founded in December 1986 and is headquartered in Boston, MA.

Data derived from most recent annual or quarterly report
Market Cap 342.611 Million Shares Outstanding24.299 Million Avg 30-day Volume 8.814 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.07
Price to Revenue1.737 Debt to Equity0.0712 EBITDA1.664 Million
Price to Book Value1.992 Operating Margin-5.357 Enterprise Value79.223 Million
Current Ratio2.569 EPS Growth-1.093 Quick Ratio1.975
1 Yr BETA 0.8919 52-week High/Low 0.0 / Profit Margin-1.7713
Operating Cash Flow Growth-72.407 Altman Z-Score-0.5933 Free Cash Flow to Firm -10.459 Million
View SEC Filings from COB1 instead.

View recent insider trading info

Funds Holding COB1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding COB1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2016-10-26:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
    Item 3.03: Material Modifications to Rights of Security Holders
  • 8-K: filed on 2016-10-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-10-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-08-31:
    Item 8.01: Other Events
  • 8-K: filed on 2016-07-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-04-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-04-18:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2016-04-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WILSON BOYD C JR

    • Director
    0 2016-10-26 0

    MCCASKILL T GRAY

    • Director
    0 2016-10-26 0

    MCKENNEY H RAY JR

    • Director
    0 2016-10-26 0

    OHCP MGP III, LTD.

    OAK HILL CAPITAL PARTNERS III, L.P.

    OAK HILL CAPITAL MANAGEMENT PARTNERS III, L.P.

    OHCP GENPAR III, L.P.

    OHCP MGP PARTNERS III, L.P.

    • 10% Owner
    No longer subject to file 2016-10-26 0

    CARLYLE GROUP MANAGEMENT L.L.C.

    TC GROUP CAYMAN INVESTMENT HOLDINGS, L.P.

    TC GROUP CAYMAN INVESTMENT HOLDINGS SUB L.P.

    CARLYLE FINANCIAL SERVICES, LTD.

    TCG FINANCIAL SERVICES, L.P.

    CARLYLE FINANCIAL SERVICES HARBOR, L.P.

    CARLYLE GROUP L.P.

    CARLYLE HOLDINGS II GP L.L.C.

    CARLYLE HOLDINGS II L.P.

    • 10% Owner
    No longer subject to file 2016-10-26 0

    KAUFFMAN SCOTT

    • Director
    No longer subject to file 2016-10-26 0

    MARTIN J CHANDLER

    • Director
    0 2016-10-26 0

    NIELSEN DAVID L CHIEF FINANCIAL OFFICER

    • Officer
    0 2016-10-26 0

    MURPHY GREGORY P CHIEF WORKOUT OFFICER

    • Officer
    0 2016-10-26 0

    MCBRYDE ANGUS M III TREASURER

    • Officer
    0 2016-10-26 0

    REID ROBERT L PRESIDENT AND CEO

    • Officer
    • Director
    0 2016-10-26 0

    LICARI JERRY R

    • Director
    0 2016-10-26 0

    DESIMONE BETH S GENERAL COUNSEL

    • Officer
    0 2016-10-26 0

    BRESNAN JOHN

    • Director
    5,225 2014-08-15 0

    REDETT JOHN C.

    • Director
    0 2014-08-15 0

    ADAMS AUSTIN A

    • Director
    11,021 2014-06-25 0

    SIMPSON BRIAN E CEO

    • Officer
    • Director
    38,169 2014-05-23 0

    SCHMITT LOUIS A JR

    • Director
    17,368 2014-02-18 0

    NEELY R REYNOLDS JR

    • Director
    843 2013-08-20 0

    MACHOVEC NEIL W. CHIEF CREDIT OFFICER

    • Officer
    5,869 2013-05-08 0

    CARLYLE GROUP MANAGEMENT L.L.C.

    CARLYLE GROUP L.P.

    CARLYLE HOLDINGS II GP L.L.C.

    CARLYLE HOLDINGS II L.P.

    TC GROUP CAYMAN INVESTMENT HOLDINGS SUB L.P.

    • 10% Owner
    4,930,313 2012-05-02 0

    CARLYLE FINANCIAL SERVICES HARBOR, L.P.

    DBD CAYMAN HOLDINGS, LTD.

    DBD CAYMAN, LTD.

    TCG HOLDINGS CAYMAN II, L.P.

    CARLYLE FINANCIAL SERVICES, LTD.

    TCG FINANCIAL SERVICES, L.P.

    TC GROUP CAYMAN INVESTMENT HOLDINGS, L.P.

    • 10% Owner
    493,031,250 2011-10-21 0

    LAVOIE DAVID C CHIEF RISK OFFICER

    • Officer
    625,000 2011-10-21 0

    BROOKS LARRY E

    • Director
    18,707 2010-12-31 0

    YALE CARL G

    • Director
    25,000 2010-06-07 0

    CAMPBELL R LARRY EVP

    • Officer
    • Director
    59,782 2010-03-04 0

    ALEXANDER JACOB F III

    • Director
    5,354 2009-12-31 0

    LLOYD LYNN S

    • Director
    28,466 2009-12-11 0

    JORDAN THOMAS A

    • Director
    76,529 2009-11-02 0

    RUDY SUZANNE B

    • Director
    3,400 2009-09-14 0

    MCLAURIN EUGENE B

    • Director
    16,394 2009-09-14 0

    CAMPBELL JAMES M JR

    • Director
    85,694 2009-09-04 0

    RAMSAY JULIUS M III

    • Director
    95,411 2009-08-05 0

    MILLER MICHAEL C PRESIDENT AND CEO

    • Officer
    • Director
    76,533 2009-08-04 0

    FRYE DARRELL L

    • Director
    3,800 2009-05-08 0

    HUFFMAN HAL F JR

    • Director
    44,588 2009-02-23 0

    SEVERSON MARK A

    • Director
    9,167 2008-11-21 0

    CLINE DAVID E

    • Director
    15,730 2007-05-01 0

    HUNTLEY ROBERT P

    • Director
    38,726 2007-04-27 0

    HENSLEY R MARK EVP OF SUBSIDIARY

    • Officer
    2,500 2007-04-05 0

    BRATTON ROBERT O EVP

    • Officer
    0 2006-09-21 0

    LITTLE JERRY A SECRETARY/ TREASURER

    • Officer
    10,437 2006-07-19 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments